Alesta Therapeutics
Leiden
About Alesta Therapeutics
Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic approaches to treat cancer
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $67.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: alestatherapeutics.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/alesta-therapeutics-90207 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.